Illimis Therapeutics News and Activities

Acquisition, funding and merger involving Illimis Therapeutics.

• Illimis Therapeutics has just announced a $42 Million fundraising (posted on July 14 2025).

View the org chart displaying its 5 main executives

Most searched biographies at Illimis Therapeutics

• Sanghoon Park, Chief Executive Officer
• Jungu Bae, Head, Research and Development Strategy
• Ahyoung Shin, Head, Business Development

Create your alert
to follow the executive moves at Illimis Therapeutics.

Illimis Therapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..
• Chemomab and Scipher Medicine have announced they will merge  (posted on July 13 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Illimis Therapeutics

Social media about Illimis Therapeutics

• Illimis Therapeutics on Wikipedia, Google News & Yahoo Finance
• Illimis Therapeutics on LinkedIn, X (Twitter) & YouTube